BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29870405)

  • 1. Evolution in Prostate Cancer Staging: Pathology Updates From AJCC 8th Edition and Opportunities That Remain.
    Fine SW
    Adv Anat Pathol; 2018 Sep; 25(5):327-332. PubMed ID: 29870405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Organ-confined Prostate Cancer, Tumor Quantitation Not Found to Aid in Prediction of Biochemical Recurrence.
    Ito Y; Vertosick EA; Sjoberg DD; Vickers AJ; Al-Ahmadie HA; Chen YB; Gopalan A; Sirintrapun SJ; Tickoo SK; Eastham JA; Scardino PT; Reuter VE; Fine SW
    Am J Surg Pathol; 2019 Aug; 43(8):1061-1065. PubMed ID: 31107718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of subclassification (pT2 stage) of pathologically organ-confined prostate cancer: Confirmation of the changes introduced in the 8th edition of the American Joint Committee on Cancer (AJCC) staging system.
    Antunes HP; Parada B; Carvalho J; Eliseu M; Jarimba R; Oliveira R; Tavares-da-Silva E; Figueiredo A
    Arch Ital Urol Androl; 2018 Sep; 90(3):191-194. PubMed ID: 30362685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers.
    Paner GP; Stadler WM; Hansel DE; Montironi R; Lin DW; Amin MB
    Eur Urol; 2018 Apr; 73(4):560-569. PubMed ID: 29325693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of the UICC and AJCC 8th edition tumor-nodes-metastasis (TNM) classification for patients treated with radical prostatectomy.
    Herden J; Heidenreich A; Wittekind C; Weissbach L
    Cancer Epidemiol; 2018 Oct; 56():126-132. PubMed ID: 30176542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the major changes in eighth edition of the American Joint Committee on Cancer pathological staging for prostate cancer treated with prostatectomy.
    Xiao WJ; Zhu Y; Dai B; Ye DW
    PLoS One; 2017; 12(11):e0187887. PubMed ID: 29121104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer collaborative stage data items--their definitions, quality, usage, and clinical implications: a review of SEER data for 2004-2010.
    Schymura MJ; Sun L; Percy-Laurry A
    Cancer; 2014 Dec; 120 Suppl 23():3758-70. PubMed ID: 25412388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of four kallikrein markers for pathologically insignificant compared with aggressive prostate cancer in radical prostatectomy specimens: results from the European Randomized Study of Screening for Prostate Cancer section Rotterdam.
    Carlsson S; Maschino A; Schröder F; Bangma C; Steyerberg EW; van der Kwast T; van Leenders G; Vickers A; Lilja H; Roobol MJ
    Eur Urol; 2013 Nov; 64(5):693-9. PubMed ID: 23683475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of perineural invasion in patients who underwent radical prostatectomy for localized prostate cancer.
    Dell'Atti L
    J BUON; 2016; 21(5):1219-1223. PubMed ID: 27837626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rising PSA Level in an Anxious Postprostatectomy Patient.
    Qi R; Moul JW
    Oncology (Williston Park); 2016 Sep; 30(9):834-7, 860. PubMed ID: 27633415
    [No Abstract]   [Full Text] [Related]  

  • 11. Percent tumor volume vs American Joint Committee on Cancer staging system subclassification for predicting biochemical recurrence in patients with pathologic T2 prostate cancer.
    Choi SY; Chi BH; Lim B; Kyung YS; You D; Jeong IG; Song C; Hong JH; Ahn H; Kim CS
    J Cancer Res Clin Oncol; 2020 Feb; 146(2):537-543. PubMed ID: 31915914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updates on Grading and Staging of Prostate Cancer.
    Braunhut BL; Punnen S; Kryvenko ON
    Surg Pathol Clin; 2018 Dec; 11(4):759-774. PubMed ID: 30447840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Prostate Cancer Stage Groups Updated in the 8th Edition of the American Joint Committee on Cancer Tumor-Node-Metastasis Staging Manual.
    Lee H; Lee M; Byun SS; Lee SE; Hong SK
    Clin Genitourin Cancer; 2019 Feb; 17(1):e221-e226. PubMed ID: 30472041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ability of the American Joint Committee on Cancer Staging system to predict progression-free survival after radical prostatectomy.
    May F; Hartung R; Breul J
    BJU Int; 2001 Nov; 88(7):702-7. PubMed ID: 11890240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in Prostate Cancer Metastases at Radical Prostatectomy in the United States.
    Hu JC; Nanus DM; Sedrakyan A
    Eur Urol; 2017 Jan; 71(1):147-149. PubMed ID: 27402061
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of a new nomogram to predict insignificant prostate cancer in patients undergoing radical prostatectomy.
    Kim TH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    Scand J Urol; 2017 Feb; 51(1):27-32. PubMed ID: 28168924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The AJCC 8th Edition Staging System for Soft Tissue Sarcoma of the Extremities or Trunk: A Cohort Study of the SEER Database.
    Cates JMM
    J Natl Compr Canc Netw; 2018 Feb; 16(2):144-152. PubMed ID: 29439175
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk of biochemical recurrence based on extent and location of positive surgical margins after robot-assisted laparoscopic radical prostatectomy.
    Marcq G; Michelet A; Hannink G; Rizk J; Sauvain J; Villers A; Saffarini M; Rochat CH
    BMC Cancer; 2018 Dec; 18(1):1291. PubMed ID: 30587172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy.
    Gandaglia G; Ploussard G; Valerio M; Marra G; Moschini M; Martini A; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Afferi L; Rakauskas A; Gontero P; Mattei A; Montorsi F; Briganti A
    Eur Urol Oncol; 2020 Dec; 3(6):739-747. PubMed ID: 32847747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining the optimal method for reporting prostate cancer grade and tumor extent on magnetic resonance/ultrasound fusion-targeted biopsies.
    Gordetsky JB; Schultz L; Porter KK; Nix JW; Thomas JV; Del Carmen Rodriguez Pena M; Rais-Bahrami S
    Hum Pathol; 2018 Jun; 76():68-75. PubMed ID: 29551676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.